A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...

The deal with U.S. biotech Septerna will see the companies develop pills to treat obesity, type 2 diabetes and other ...

Attention-deficit/hyperactivity disorder (ADHD) might contribute to obesity by reducing physical activity—a relationship that ...

Learn about SYNT-101, the emerging treatment for obesity that combines the best of two proven methods.

Queen Latifah opens up about obesity and heart health risks for public awareness campaign, Truth About Weight.

Childhood obesity is a growing concern. A recent study highlights the link between belly fat in kids and heart disease risks.

Deaths attributed to both acute heart attack and obesity rose between 2007 and 2019, according to findings from the CDC ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being ...

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...

Three months of 8-hour time-restricted eating (TRE), regardless of the time of the day, helped sustain long-term weight loss ...

Discover the differences between overweight and obesity, learn accurate measurement techniques, and find practical strategies ...

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...